Incubator Weaning of Moderately Preterm Infants
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02160002|
Recruitment Status : Completed
First Posted : June 10, 2014
Results First Posted : December 21, 2017
Last Update Posted : March 22, 2019
- Study Details
- Tabular View
- Study Results
- How to Read a Study Record
The objective of this proposal is to evaluate whether weaning from an incubator to a crib at lower versus higher weight, 1600g or 1800g will result in shorter length of hospital stay among moderately preterm infants.
The hypothesis of this study is that length of hospital stay (from birth to discharge) will be decreased among moderate preterm infants weaned from an incubator to an open crib at a lower versus higher weight, 1600g vs. 1800g.
|Condition or disease||Intervention/treatment||Phase|
|Infant, Newborn Infant, Moderate Preterm||Procedure: Weaning from an incubator at a lower weight (1600 grams) Procedure: Weaning from an incubator at a higher weight (1800 grams)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||366 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Incubator Weaning of Moderately Preterm Infants: A Randomized Controlled Trial|
|Actual Study Start Date :||February 2015|
|Actual Primary Completion Date :||July 2016|
|Actual Study Completion Date :||June 2017|
Active Comparator: Lower Weight (1600 grams)
Weaning from an incubator at a lower weight (1600 grams)
Procedure: Weaning from an incubator at a lower weight (1600 grams)
Infants will be weaned from an incubator at a lower weight (1600 grams)
Active Comparator: Higher Weight (1800 grams)
Weaning from an incubator at a higher weight (1800 grams)
Procedure: Weaning from an incubator at a higher weight (1800 grams)
Infants will be weaned from an incubator at a higher weight (1800 grams)
- Length of Hospital Stay (LOS) From Birth to Discharge (up to 120 Days) [ Time Frame: From birth through discharge ]Number of days the infant stays in hospital after birth until discharge home (up to 120 days).
- Length of Stay (LOS) Following Weaning From Incubator to Crib to Hospital Discharge (up to 120 Days) [ Time Frame: From start of weaning from the incubator to crib through discharge (up to 120 days) ]Among infants who were successfully weaned, the number of days in the hospital counting from the start of weaning from the incubator to the crib through discharge from the hospital (up to 120 days).
- Failure Rate of Weaning to Crib (Number of Infants With Axillary Temperature < 36.3°C After 2 Weaning Attempts) [ Time Frame: Through completion of 2 weaning attempts ]Failure of wean is defined as axillary temperature less than 36.3°C after one hour in the crib on 2 successive readings, 3 to 4 hours apart, within 24 hours of weaning to the crib in spite of additional clothes/coverings.
- Growth Velocity (Weight in Grams/kg/Day) From Start of Weaning From Incubator (Following Random Assignment) to 36 Weeks Postmenstrual Age (PMA) [ Time Frame: Start of weaning from incubator through 36 weeks postmenstrual age (PMA) ]Growth velocity in terms of weight (g/kg/day), considering infant weight at start of weaning from incubator to crib (following random assignment) and weight at 36 weeks postmenstrual age (PMA).
- Growth Parameters: Weight at Status [ Time Frame: Status (discharge, death, transfer to another facility, or 120 days) ]Infant weight at status is measured at the time of discharge, death, transfer to another facility, or 120 days.
- Growth Parameters: Length at Status [ Time Frame: Status (discharge, death, transfer to another facility, or 120 days) ]Infant length at status is measured at the time of discharge, death, transfer to another facility, or 120 days.
- Growth Parameters: Head Circumference at Status [ Time Frame: Status (discharge, death, transfer to another facility, or 120 days) ]Infant head circumference at status is measured at the time of discharge, death, transfer to another facility, or 120 days.
- Postmenstrual Age (PMA) at Discharge [ Time Frame: Discharge ]Postmenstrual age (PMA) at discharge is the sum of the gestational age of the infant and its length of stay in hospital from birth to discharge.
- Readmission to the Hospital Within 1 Week of Discharge [ Time Frame: Discharge through 1 week after discharge. ]Number of infants re-hospitalized within 1 week (7 days) of discharge.
- Death Among Enrolled Infants [ Time Frame: Status (discharge, death, transfer to another facility, or 120 days) ]
- Transferred to a Non-Network Hospital [ Time Frame: Status (discharge, death, transfer to another facility, or 120 days) ]Number of infants transferred to another non-Network hospital.
- Length of Stay (LOS) Following Randomization to Hospital Discharge [ Time Frame: From randomization through discharge. ]The number of days the infant stayed in hospital after randomization to the study until discharge.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||29 Weeks to 34 Weeks (Child)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
- Gestational age 29 0/7 to 33 6/7 weeks at birth
- Birth weight less than 1600 grams
- Greater than 48 hours of age
- Current weight less than 1540 grams
- In an incubator
- Receiving phototherapy
- Receiving respiratory support (including CPAP, ventilation, HFNC > 2 LPM)
- Receiving blood pressure support
- Designated for transfer to referral hospital while in incubator
- Known major congenital or chromosomal anomaly
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02160002
|Principal Investigator:||Michele C Walsh, MD||Case Western Reserve University, Rainbow Babies and Children's Hospital|
|Principal Investigator:||Myra Wyckoff, MD||University of Texas, Southwestern Medical Center at Dallas|
|Study Chair:||Seetha Shankaran, MD||Wayne State University|
|Principal Investigator:||David Carlton, MD||Emory University|
|Principal Investigator:||Kurt Schibler, MD||Children's Hospital Medical Center, Cincinnati|
|Principal Investigator:||Brenda B Poindexter, MD||Indiana University|
|Principal Investigator:||Abbot Laptook, MD||Brown University, Women & Infants Hosptial of Rhode Island|
|Principal Investigator:||Krisa P Van Meurs, MD||Stanford University|
|Principal Investigator:||Waldemar Carlo, MD||University of Alabama at Birmingham|
|Principal Investigator:||Kathleen A Kennedy, MD||The University of Texas Health Science Center, Houston|
|Principal Investigator:||Mike Cotten, MD||Duke University|
|Principal Investigator:||Edward F Bell, MD||University of Iowa|
|Principal Investigator:||Kristi Watterberg, MD||University of New Mexico|
|Principal Investigator:||Barbara Schmidt, MD||University of Pennsylvania|
|Principal Investigator:||Carl T D'Angio, MD||University of Rochester|
|Principal Investigator:||Uday Devaskar, MD||University of California, Los Angeles|
|Principal Investigator:||Pablo Sanchez, MD||Research Institute at Nationwide Children's Hospital|
|Principal Investigator:||William Truog, MD||Children's Mercy Hospital Kansas City|
|Principal Investigator:||Abhik Das, PhD||RTI International|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
|Responsible Party:||NICHD Neonatal Research Network|
|Other Study ID Numbers:||
|First Posted:||June 10, 2014 Key Record Dates|
|Results First Posted:||December 21, 2017|
|Last Update Posted:||March 22, 2019|
|Last Verified:||March 2019|
Moderately Preterm Infants
Obstetric Labor, Premature
Obstetric Labor Complications
Female Urogenital Diseases and Pregnancy Complications